Evidence map›Paper›PMID 35233291›Full record

ArticleVirus evolution2022

Wildlife in Cameroon harbor diverse coronaviruses, including many closely related to human coronavirus 229E.

Nkom F Ntumvi, Valantine Ngum Ndze, Amethyst Gillis, Joseph Le Doux Diffo, Ubald Tamoufe, Jean-Michel Takuo, Moctar M M Mouiche, Julius Nwobegahay, Matthew LeBreton, Anne W Rimoin and 10 more

Open access · goldAbstract read
In one paragraph

Article in Virus evolution, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Nkom F NtumviMetabiota Cameroon Ltd, Yaoundé, Centre Region Avenue Mvog-Fouda Ada, Av 1.085, Carrefour Intendance, Yaoundé, BP 15939, Cameroon.
Valantine Ngum Ndze
Amethyst GillisMetabiota Inc, 425 California Street, Suite 1200, San Francisco, CA 94104, USA.
Joseph Le Doux DiffoMetabiota Cameroon Ltd, Yaoundé, Centre Region Avenue Mvog-Fouda Ada, Av 1.085, Carrefour Intendance, Yaoundé, BP 15939, Cameroon.
Ubald TamoufeMetabiota Cameroon Ltd, Yaoundé, Centre Region Avenue Mvog-Fouda Ada, Av 1.085, Carrefour Intendance, Yaoundé, BP 15939, Cameroon.
Jean-Michel TakuoMetabiota Cameroon Ltd, Yaoundé, Centre Region Avenue Mvog-Fouda Ada, Av 1.085, Carrefour Intendance, Yaoundé, BP 15939, Cameroon.
Moctar M M MouicheMosaic, Yaoundé, Centre Region, BP 35353, Cameroon.ORCID https://orcid.org/0000-0002-4900-3670
Julius NwobegahayCRESAR, Yaoundé, Centre Region 7039 Carrefour Intendance, BP 15939, Cameroon.
Matthew LeBreton
Anne W RimoinDepartment of Epidemiology, University of California, 71-254 Center for Health Sciences, 650 Charles E. Young Drive South, Los Angeles, CA 90095, USA.
Bradley S SchneiderMetabiota Inc, 425 California Street, Suite 1200, San Francisco, CA 94104, USA.ORCID https://orcid.org/0000-0001-7642-0018
Corina Monagin
David J McIverMetabiota Inc, 7-1611 Bowen Road, Nanaimo BC V9S 1G5, Canada.
Sanjit RoyLabyrinth Global Health, 546 15TH Ave NE, St.Petersburg, FL 33704, USA.
James A AyukekbongMetabiota Inc, 7-1611 Bowen Road, Nanaimo BC V9S 1G5, Canada.
Karen E SaylorsLabyrinth Global Health, 546 15TH Ave NE, St.Petersburg, FL 33704, USA.
Damien O JolyMetabiota Inc, 7-1611 Bowen Road, Nanaimo BC V9S 1G5, Canada.
Nathan D Wolfe
Edward M RubinMetabiota Inc, 425 California Street, Suite 1200, San Francisco, CA 94104, USA.
Christian E LangeMetabiota Inc, 7-1611 Bowen Road, Nanaimo BC V9S 1G5, Canada.ORCID https://orcid.org/0000-0002-0664-9367
Metabiota (Cameroon) · CMMetabiota (United States) · USUniversité de Yaoundé I · CMUniversity of Development Alternative · BDInstitut de Recherche Agricole pour le Développement · CMOklahoma State University Center for Health Sciences · USUniversity of California, Davis · USUniversity of Victoria · CA

Funding

NIH Director's Pioneer Award (RMI)DP1OD000370 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOLFE, NATHAN D · 2005 to 2009
$3.4M
THE EMERGENCE OF HIV GENETIC DIVERSITY IN CAMEROONK01TW000003 · FIC · JOHNS HOPKINS UNIVERSITY · PI WOLFE, NATHAN D · 1999 to 2005
$634k
FIC NIH HHS K01 TW000003NIH HHS DP1 OD000370
6 · The paper itself

Abstract

Zoonotic spillover of animal viruses into human populations is a continuous and increasing public health risk. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the global impact of emergence. Considering the history and diversity of coronaviruses (CoVs), especially in bats, SARS-CoV-2 will likely not be the last to spillover from animals into human populations. We sampled and tested wildlife in the Central African country Cameroon to determine which CoVs are circulating and how they relate to previously detected human and animal CoVs. We collected animal and ecological data at sampling locations and used family-level consensus PCR combined with amplicon sequencing for virus detection. Between 2003 and 2018, samples were collected from 6,580 animals of several different orders. CoV RNA was detected in 175 bats, a civet, and a shrew. The CoV RNAs detected in the bats represented 17 different genetic clusters, coinciding with alpha (

Indexed as

batscameroonCoronavirusHCoV-229Eseasonalitywildlife

Identifiers

PMID35233291
PMCPMC8867583
OpenAlexW4205679550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.